LONDON, Aug. 9, 2011 /PRNewswire/ -- Marken Ltd., a leading life sciences supply chain management organization, today announced the appointment of Christopher O’Connell as their new Chief Financial Officer (CFO) effective August 1, 2011.
Mr. O’Connell joins Marken with more than 20 years experience in the laboratory manufacturing and distribution services, construction and public accounting industries. He most recently worked for Thermo Fisher Scientific as Vice President of Finance for the Customer Channels Group, a multi-billion dollar, multi-national laboratory distribution and services group. Thermo Fisher serves pharmaceutical and biotech companies, hospitals, clinical diagnostic labs, universities, research institutions and government agencies and has a portfolio of over 800,000 products.
Mr. O’Connell also served Fisher in various roles which involved the development of the company’s portfolio strategies, acquisitions and integration of new companies, management of shared service functions as well as having full income statement responsibilities across multiple business lines.
“Chris’ business insight, combined with his extensive financial leadership, acquisition integration expertise and pharmaceutical services and supplies familiarity at Thermo Fisher, make him an excellent addition to our executive leadership team. Our business expansion strategies will benefit enormously from Chris’s background and leadership qualities.” said Wes Wheeler, Chief Executive Officer of Marken.
Mr. O’Connell holds a Bachelor of Business Administration from Siena College and is a Certified Public Accountant.
About Marken
Founded in 1980, Marken is focused on supporting life science companies by managing their clinical supply chain and logistics through the entire clinical trial process. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naïve geographies. As the leading logistics company managing global collection, transportation, storage and distribution of specimens and clinical trial supplies, Marken supports the clinical supply chain to over 6000 investigator sites in excess of 100 countries. Marken’s team members and network of facilities bridge the distance between patients and the essential resources of life science companies.
SOURCE Marken
